The Oxidation Problem: Most Fish Oil Is Rancid
Omega-3 polyunsaturated fatty acids (PUFAs) are chemically unstable. The multiple double bonds that give EPA and DHA their biological activity also make them highly susceptible to oxidative degradation. When fish oil oxidizes, the EPA and DHA are destroyed and replaced with aldehydes, ketones, and other oxidation byproducts. Some of these byproducts are biologically harmful.
The industry uses three metrics to assess oxidation: Peroxide Value (PV)—measures primary oxidation products; Anisidine Value (AnV)—measures secondary oxidation products (the more harmful aldehydes that form after primary oxidation); and TOTOX Score (2 x PV + AnV)—the composite oxidation metric. Acceptable limits: PV ≤5 mEq/kg, AnV ≤20, TOTOX ≤26 (European Pharmacopoeia / GOED standards).
Independent testing consistently finds that the majority of commercial fish oil products exceed these limits. ConsumerLab's periodic testing has found 50–70% of tested products above acceptable TOTOX thresholds. IFOS (International Fish Oil Standards Program) testing similarly finds widespread oxidation issues. Rancid fish oil is not just ineffective—the oxidation byproducts may actively promote inflammation rather than resolve it, the opposite of the intended effect.
How to avoid oxidized fish oil: Buy from brands that publish TOTOX scores per lot. Look for IFOS 5-Star certification or NSF certification. Refrigerate after opening. Choose products with nitrogen-flushed packaging. Avoid fish oil that tastes or smells strongly of fish—fresh fish oil has a mild smell; strong fishiness signals oxidation.
Ethyl Ester vs Triglyceride Form: Bioavailability Matters
Fish oil comes in two primary molecular forms: ethyl ester (EE) and triglyceride (TG), which includes natural TG (nTG) and re-esterified TG (rTG).
Natural fish oil is in triglyceride form. When fish oil is concentrated and purified (to remove contaminants and increase EPA/DHA percentage), it is typically first converted to ethyl ester form as an intermediate step. Many products are sold in this EE form because it is cheaper to produce. Some manufacturers take the additional step of converting the EE back to TG form (re-esterified TG, or rTG), which more closely mimics the natural molecular structure.
Dyerberg et al. 2010 (Prostaglandins, Leukotrienes and Essential Fatty Acids) conducted a crossover study comparing fasted-state absorption of nTG, rTG, EE, and free fatty acid (FFA) fish oil. The nTG and rTG forms were absorbed approximately 70% more efficiently than EE in fasted conditions. When taken with a high-fat meal, the difference narrows (fat stimulates bile and pancreatic lipase release, which improve EE digestion), but the TG form remains superior under both fed and fasted conditions.
Implication: two products listing "1000mg EPA+DHA" deliver meaningfully different amounts to tissues depending on molecular form. A 1000mg EPA+DHA in rTG form delivers roughly as much omega-3 to tissues as 1260–1700mg EPA+DHA in EE form. Most high-volume budget fish oil is in EE form.
EPA vs DHA: Different Functions, Different Targets
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are both omega-3 fatty acids but have distinct biological roles. Understanding the difference allows you to match the EPA:DHA ratio to your specific goal.
EPA's primary roles: Substrate for anti-inflammatory eicosanoid synthesis (EPA-derived prostaglandins and thromboxanes are anti-inflammatory relative to the arachidonic acid-derived equivalents). EPA is the substrate for resolvin E-series (RvE1, RvE2)—specialized pro-resolving mediators that actively terminate inflammation rather than just suppressing it. EPA reduces triglycerides, has mood-stabilizing properties in depression (evidence suggests EPA is the more active antidepressant omega-3), and has demonstrated cardiovascular protection in the REDUCE-IT trial at high doses.
DHA's primary roles: Structural component of neuronal and retinal cell membranes—DHA represents ~30% of the fatty acids in the mammalian brain's gray matter and ~50% of the fatty acids in photoreceptor outer segments. DHA is the substrate for resolvin D-series and protectins, which also promote inflammation resolution. DHA is critical during fetal neurodevelopment and in early infancy. DHA supplementation shows benefits for cognitive aging and may be neuroprotective in traumatic brain injury.
Standard fish oil typically provides a ~1.5:1 or 2:1 EPA:DHA ratio. High-EPA products (like Vascepa, the pharmaceutical EPA used in REDUCE-IT) are pure EPA. High-DHA products are available for cognitive and infant/maternal applications. Most people need both EPA and DHA—the specific ratio matters primarily when targeting a specific condition.
The REDUCE-IT vs STRENGTH Controversy
Two major cardiovascular outcomes trials came to starkly different conclusions about omega-3 supplementation, and understanding why matters for interpreting the evidence.
REDUCE-IT (Bhatt et al. 2018, NEJM, n=8,179): High-dose icosapentaenoic acid (EPA only, 4g/day as Vascepa) reduced major adverse cardiovascular events by 25% vs mineral oil placebo. This was a statistically significant and clinically meaningful outcome that led to FDA approval of Vascepa for cardiovascular risk reduction.
STRENGTH (Nicholls et al. 2020, JAMA, n=13,078): High-dose EPA+DHA (4g/day as Epanova, a free fatty acid form) showed no cardiovascular benefit vs corn oil placebo. The trial was stopped early for futility.
The contrast has generated significant debate. Three possible explanations are most discussed: (1) EPA-only is the active cardiovascular-protective agent and DHA attenuates EPA's effects; (2) The mineral oil placebo in REDUCE-IT was itself pro-inflammatory (inflating the apparent benefit of EPA); (3) The free fatty acid form in STRENGTH has different bioavailability and metabolic effects than the EE form used in REDUCE-IT. The mechanistic debate remains open. For practical supplementation at consumer doses (1–3g EPA+DHA/day), neither trial directly applies—both used 4g EPA or EPA+DHA/day, 2–4x what most supplements provide.
Brand Comparison: Who Passes Independent Testing
| Brand / Product | Form | EPA/DHA per Serving | 3rd Party Cert | Notes |
|---|---|---|---|---|
| Nordic Naturals Ultimate Omega | rTG (re-esterified TG) | 1,280mg EPA+DHA / 2 softgels | IFOS 5-Star | Consistently passes IFOS oxidation testing; widely available; good EPA:DHA ratio (650mg EPA / 450mg DHA per serving) |
| Carlson Elite Omega-3 | TG | 1,600mg EPA+DHA / 2 softgels | IFOS certified | High dose per serving; natural TG form; IFOS certified; competitive price per gram EPA+DHA |
| Thorne Super EPA | EE | 1,000mg EPA+DHA / 2 softgels | NSF Certified for Sport | Pharmaceutical-grade manufacturing; NSF Sport certified; EE form (note lower bioavailability vs TG); trusted by practitioners |
| Viva Naturals Triple Strength | rTG | 2,200mg EPA+DHA / 3 softgels | IFOS certified | High dose; rTG form; competitive price; IFOS certified; good option for high-dose protocols |
| Kirkland Signature (Costco) | EE | 684mg EPA+DHA / 2 softgels | USP verified | Budget-friendly; USP verified for label accuracy; EE form; adequate for maintenance dosing; rancidity testing inconsistent across lots |
| Most generic/store brand fish oils | EE (typically) | Variable; often lower than label claims | None or minimal | Majority fail IFOS oxidation standards; EE form; label inaccuracy common; avoid without independent verification |
Omega-3 Protocol: Evidence-Based Dosing by Goal
- General health maintenance: 1–2g combined EPA+DHA/day in TG or rTG form. Take with the largest meal of the day to maximize absorption (fat stimulates bile and lipase, improving omega-3 absorption). Choose a product with IFOS or NSF certification. Nordic Naturals Ultimate Omega and Carlson Elite are reliable starting choices.
- Cardiovascular risk reduction: 2–4g EPA+DHA/day, ideally with higher EPA ratio. The REDUCE-IT data was with 4g pure EPA/day—an amount not achievable with most consumer products without multiple servings. High-dose protocols at this level should be coordinated with a physician, as omega-3s at high doses modestly impair platelet aggregation.
- Inflammation and joint health: 2–3g EPA/day. EPA is the primary anti-inflammatory and pro-resolving omega-3; choose high-EPA products. Consistent daily use for 6–12 weeks is required before meaningful anti-inflammatory effects are measurable.
- Cognitive and neurological health: 1–2g DHA/day. DHA is the primary structural omega-3 in neuronal membranes. Choose products with higher DHA ratios (DHA-dominant formulas) or algae-based DHA for vegan/vegetarian applications.
- Pregnancy and infant development: 200–300mg DHA/day minimum (EFSA guidance); many prenatal protocols use 600–900mg DHA/day. Choose products tested for heavy metals (mercury, PCBs) and oxidation. Algae-based DHA is the safest form due to absence of heavy metal accumulation.
- Quality check at home: Cut open a softgel and smell the oil. Fresh omega-3 oil should smell mild and ocean-like. A strong fishy, rancid, or paint-like smell indicates oxidation. Discard the product.
Re-esterified triglyceride (rTG) form for superior absorption. IFOS 5-Star certified for oxidation and purity. 1,280mg EPA+DHA per 2-softgel serving. Consistently passes independent third-party testing. Available in lemon flavor to mask any residual fishiness.
Natural triglyceride form at 1,600mg EPA+DHA per 2-softgel serving. IFOS certified. Carlson has a long track record of passing independent oxidation testing. Good choice for individuals targeting higher daily EPA+DHA intake.
Fish obtain their EPA and DHA from algae. Algae-based omega-3 bypasses fish entirely, eliminating heavy metal exposure risk and providing DHA in a sustainable form. Primary choice for vegans, vegetarians, and during pregnancy. Nordic Naturals Algae Omega and Ovega-3 are well-reviewed options.